SP
Suchitra Pusapati
About Suchitra Pusapati
Data last updated:
Suchitra Pusapati has 10 years in corporate governance. Holds Director role. Currently with 1 company, including Ske Susruta Institute Of Medical Sciences Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Ske Susruta Institute Of Medical Sciences Private Limited at ₹3.38 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Dec 2015 | 2011 | ₹3.38 Cr (FY 2025) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Suchitra Pusapati
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Suchitra Pusapati
Suchitra Pusapati has 10 years in corporate governance. Holds Director role. Currently with 1 company, including Ske Susruta Institute Of Medical Sciences Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Ske Susruta Institute Of Medical Sciences Private Limited at ₹3.38 Cr (FY 2025).
Suchitra Pusapati is associated with 1 company as Director, including Ske Susruta Institute Of Medical Sciences Private Limited (₹3.38 Cr).
Suchitra Pusapati has expertise in General Business.
Suchitra Pusapati has 10 years in corporate governance.
By reported revenue, the largest current company of Suchitra Pusapati is Ske Susruta Institute Of Medical Sciences Private Limited, with revenue of ₹3.38 Cr (FY 2025).
Suchitra Pusapati currently holds positions at 1 company: Ske Susruta Institute Of Medical Sciences Private Limited (₹3.38 Cr).